Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT00757614 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 14000
Last updated 2013-08-26
Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This study is looking at genetic susceptibility to cancer and interactions between genes and the environment in patients with cancer in East Anglia, Trent, or West Midlands of the United Kingdom.
Conditions
- Bladder Cancer
- Brain and Central Nervous System Tumors
- Esophageal Cancer
- Intraocular Melanoma
- Kidney Cancer
- Lymphoma
- Melanoma (Skin)
- Pancreatic Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
Interventions
- GENETIC
-
DNA analysis
- GENETIC
-
polymorphism analysis
- OTHER
-
laboratory biomarker analysis
- OTHER
-
questionnaire administration
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Paul Pharoah, MD · Cancer Research UK
Eligibility
- Min Age
- 18 Years
- Max Age
- 69 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-02-29
Countries
- United Kingdom
Study Locations
More Related Trials
-
Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs
NCT02458040 ·Status: WITHDRAWN
-
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
NCT00003329 ·Status: COMPLETED
-
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
NCT01034033 ·Status: RECRUITING
-
A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration
NCT06564428 ·Status: RECRUITING
-
Inherited Susceptible Genes Among Epithelial Ovarian Cancer
NCT03015376 ·Status: UNKNOWN
-
Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
NCT00450593 ·Status: UNKNOWN
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer
NCT03922893 ·Status: RECRUITING
-
Rare Tumors and Cancer Predisposition in Individuals and Families
NCT05350761 ·Status: RECRUITING
-
Genetic Investigation of Cancer Predisposition
NCT04620278 ·Status: NOT_YET_RECRUITING
-
Single-institution Register of Individuals Undergoing Cancer Genetic Risk Assessment
NCT06800599 ·Status: ENROLLING_BY_INVITATION
-
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer
NCT02560818 ·Status: COMPLETED ·Phase: NA
-
Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
NCT00991991 ·Status: TERMINATED
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING
-
Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients
NCT02706652 ·Status: TERMINATED
-
Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer
NCT01198171 ·Status: COMPLETED
-
Genomic Analysis of Families With a History of Discordant Cancers
NCT04860453 ·Status: RECRUITING
-
Clinical Outcomes in Hereditary Cancer
NCT00580021 ·Status: WITHDRAWN
-
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
NCT06274541 ·Status: COMPLETED
-
The Registration Program of BRCA1/2 Gene
NCT02593435 ·Status: UNKNOWN
-
Detection of Tumor DNA in Blood Samples From Cancer Patients
NCT02288754 ·Status: UNKNOWN
-
Clinical and Laboratory Analysis of Familial Cancer
NCT02565004 ·Status: COMPLETED
-
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
NCT00283530 ·Status: TERMINATED
-
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer
NCT02790944 ·Status: COMPLETED
-
Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
NCT00974610 ·Status: COMPLETED